Pfizer Pill Reduces Risk of Hospitalization and Death By 89%

This morning Pfizer announced updated results for it’s experimental treatment for Covid-19. The pill, called Paxlovid, cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their symptoms. Pfizer hopes to eventually offer the pill for people to take at home before becoming sick enough to require hospital treatment. ‘Paxlovid’ combines a new antiviral drug Nirmatrelvir and an older drug called Ritonavir. The study found five hospitalizations and no deaths among it’s 697 participants who received the drug within the first three days of symptoms. Among 682 who received the placebo, 44 were hospitalized and nine died, all of the participants were unvaccinated. The company made a similar announcement last month before all the data had come in.